TTNP Titan Pharmaceuticals, Inc. (de)

Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Titan Pharmaceuticals, Inc. (de) market cap is $7.12M.

52 week high is the highest price of a stock in the past 52 weeks, or one year. Titan Pharmaceuticals, Inc. (de) 52 week high is $1.24 as of October 01, 2023.

52 week low is the lowest price of a stock in the past 52 weeks, or one year. Titan Pharmaceuticals, Inc. (de) 52 week low is $0.428 as of October 01, 2023.

Titan Pharmaceuticals, Inc. (de) stock price today is $0.474.

Titan Pharmaceuticals, Inc. (de) stock price yesterday was $0.4737.

The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Titan Pharmaceuticals, Inc. (de)’s P/E ratio is -0.83.

The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Titan Pharmaceuticals, Inc. (de) P/B ratio is -6.8835.

EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Titan Pharmaceuticals, Inc. (de)'s EBITDA is -1.16.

The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Titan Pharmaceuticals, Inc. (de) 50-day moving average is $0.5126.

Titan Pharmaceuticals, Inc. (de) has 4 employees.